Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for HCV Suppression in HSV-1+/HSV-2- Veterans
NCT01580995Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Apr 2012
- Primary completion
- Dec 2014
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of valaciclovir in hepatitis C (HCV), sponsored by VA Office of Research & Development. Started Apr 2012; status: completed.
02
Drugs
valaciclovir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01580995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01580995.